Edesa Biotech Inc expected to post a loss of 71 cents a share - Earnings Preview

Edesa Biotech

12/12/2023 14:03

* Edesa Biotech Inc  EDSA.OQ   EDSA.O  is expected to show
no
change in quarterly revenue when it reports  results on December
14 (estimated) for the period ending June 30 2023
    * 
    * ​LSEG's mean analyst estimate for Edesa Biotech Inc is for
a
loss of 71 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $30.00​, above​ its last closing price of $4.51. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2023  -1.10       -1.21      -0.70     Beat    42.3
 Mar. 31 2023  -0.98       -1.21      -0.84     Beat    30.8
 Dec. 31 2022  -1.32       -1.33      -0.91     Beat    31.6​
 Sep. 30 2022              -2.76      -0.14     Beat    94.9
 ​​Jun.        -3.01       -3.01      -2.59     Beat    14
 30 2022                                                
 Mar. 31 2022  -2.38       -2.57      -2.31     Beat    10​
 Dec. 31 2021  -2.80       -2.80      -2.31     Beat    17.5
 Sep. 30 2021  -2.89       -2.57      -1.89     Beat    26.4
 This summary was machine generated December 12 at 14:03 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)